Company Quick10K Filing
Pro Dex
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-K 2019-06-30 Annual: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-Q 2018-12-31 Quarter: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-K 2018-06-30 Annual: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-K 2017-06-30 Annual: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-K 2016-06-30 Annual: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-K 2015-06-30 Annual: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-K 2014-06-30 Annual: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-Q 2013-12-31 Quarter: 2013-12-31
8-K 2019-11-21 Shareholder Vote
8-K 2019-11-07 Earnings, Exhibits
8-K 2019-09-30 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-08-29 Earnings, Exhibits
8-K 2019-08-09 Officers
8-K 2019-06-12 Other Events
8-K 2019-05-09 Earnings, Exhibits
8-K 2019-05-01 Other Events, Exhibits
8-K 2019-03-25 Officers
8-K 2019-03-14 Other Events
8-K 2019-02-07 Earnings, Exhibits
8-K 2019-01-12 Officers
8-K 2018-11-15 Shareholder Vote
8-K 2018-11-12 Officers
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-09-19 Other Events
8-K 2018-09-04 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2018-08-30 Earnings, Exhibits
8-K 2018-08-16 Officers
8-K 2018-05-23 Enter Agreement, M&A, Exhibits
8-K 2018-04-16 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-04-11 Enter Agreement, Exhibits
8-K 2018-03-14 Other Events

Pro Dex Financials

-

PDEX Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Pavmed (PAVM) 38,577 7,060 8,940 0 0 -6,485 -5,093 31,669
Restoration Robotics (HAIR) 25,740 23,175 36,157 19,801 8,882 -30,382 -29,504 42,050
Retractable Technologies (RVP) 23,852 36,263 10,497 35,655 10,716 50 1,087 22,920
Dynatronics (DYNT) 14,310 39,632 18,876 62,565 19,174 -336 -1,740 14,358
Isoray (ISR) 28,303 9,422 1,742 5,390 3,047 -5,144 -5,144 22,796
Dariohealth (DRIO) 21,001 12,326 6,232 7,472 1,575 -19,804 -19,804 13,015
Biolase (BIOL) 33,040 32,362 28,570 42,952 16,456 -20,383 -19,229 44,008
Ra Medical Systems (RMED) 45,828 69,280 9,483 5,800 1,378 -34,418 -34,350 -9,301
Co-Diagnostics (CODX) 13,864 5,318 512 85 37 -6,302 -6,247 10,008
Lianluo Smart (LLIT) 21,368 5,699 2,582 0 0 0 0 20,891
Hancock Jaffe Laboratories (HJLI) 18,997 7,253 2,601 103 72 -6,770 -6,653 13,722
Alliqua Biomedical (ALQA) 17,714 2,703 11,954 937 -10 -7,586 -5,012 19,826
Cytori Therapeutics (CYTX) 92 8,884 15,160 2,983 230 -16,863 -13,050 6,335
Invivo Therapeutics Holdings (NVIV) 6,891 13,608 3,140 0 0 -11,479 -11,414 -3,121
Neurometrix (NURO) 5,087 10,814 5,957 5,478 3,604 -3,028 -3,028 128
Inspiremd (NSPR) 5,030 9,284 3,710 3,360 794 -9,637 -9,637 207
Presbia (LENS) 4,530 2,986 20 -31 -8,416 -8,408 -2,527
InfuSystem (INFU) 72,361 72,643 72,156 41,089 -1,373 9,251 31,860
Daxor (DXR) 31,097 85,725 49,508 0 0 0 0 31,038
Pro Dex (PDEX) 8,812 25,520 8,512 28,594 10,531 5,017 6,991 5,673

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash4,2674,8794,1123,1252,5492,0391,6801,8291,5541,9263,1883,6091,9731,4756974931,0531,4522,2942,1682,1803,6994,2055,8555,2625,0995,1888,3158,8719,6617,742
Accounts Receivable2,2482,2281,5811,8391,1751,5771,3391,3611,5801,1021,7761,0941,1152,0992,3267591,8312,1691,4691,5421,0263,8853,5382,2543,1503,4342,9553,6243,8073,7424,100
Inventory4,7333,0592,7913,4823,5153,7463,8343,9733,5523,1842,6002,5872,8803,4444,3104,2514,4814,1183,5733,3703,2722,9753,0853,5123,1963,3824,3934,5654,5404,8056,239
PP&E3,5592,5979,0422,4292,2902,1879,1451,9261,7941,6828,9401,4731,5621,6048,8971,3371,2251,1989,0541,5831,4581,5049,2271,4271,8421,7398,4792,1482,1152,5119,483
Assets15,30814,40012,82212,57211,32111,25110,59510,45310,38910,19011,70811,54511,94512,61512,51612,27012,16711,51711,14711,92915,03415,38916,35118,16718,81319,48219,91725,19424,02625,63125,520
Accounts Payable1,6241,0296331,1075769818444826266037446178301,5341,8671,2091,2861,1328411,1847619461,1599439238731,0831,1979701,5431,996
Long-Term Debt
Liabilities4,7974,3353,2723,0092,0202,6552,6582,2292,3422,5192,4922,4833,0624,2134,0383,9103,4012,3772,2702,8032,8332,4282,6411,8922,0682,0532,6417,4677,0447,9778,512
Stockholders' Equity10,51110,0659,5509,5639,3018,5967,9378,2248,0477,6719,2169,0628,8838,4028,4788,3608,7669,1408,8779,12612,20112,96113,71016,27516,74517,42917,27617,72716,98217,65417,008
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue4,9074,5393,6563,4613,0073,0602,7222,5552,6402,4053,2132,5952,9833,9234,0734,0975,4395,3375,2855,4124,5996,6185,5975,1625,5605,4946,2486,9167,8206,8547,004
Cost of Revenue3,5043,3362,7982,2251,9742,1772,1571,6102,0911,8642,2821,7672,0962,8782,9383,0393,9003,9773,8393,8043,2884,1563,6073,3023,8433,5183,8594,1894,8214,5914,462
Gross Profit1,4031,2038581,2361,0338835659456115419318289841,0451,1351,0581,5391,3601,4461,6081,3112,4621,9901,8601,7171,9762,3892,7272,9992,2632,542
R&D607486513406464490430375364381361384448480359428435450539476278257386407478560448408326603545
SG&A1,0781,3891,1468829491,164827549561603586633716955705748708615708726764857781591663784607598730763817
Tax1121-1604170-168-8498-40016919-2,859650168262167223114433394191280
Net Income-292-486-544-17-348-747-672212621-38524-17023-7673-1253913681892863,1948887166283454801681,3492,048732888
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating627-576-172-49010-512-13430314523-260-7011,0402425071,3076368721,577241
Cash Investing74-96-41-20-384661-13965-264-97-1,280297-1,561-913-633-1,008-1,2931,286-525-690
Cash Financing-89-95-7740150-241,512-5-96-942,17178-37-2103,784-1,602-262-1,470